Active substance
Results for the substance botulinum toxin type b
1 result
About this active substance
Botulinum toxin type B is a neurotoxin produced by the bacterium Clostridium botulinum, used therapeutically to treat cervical dystonia and other neuromuscular disorders. It works by blocking the release of acetylcholine at the neuromuscular junction, leading to relaxation of muscles affected by spasms or involuntary contractions.
Botulinum toxin type B is administered via intramuscular injections, with the dose adjusted based on the severity of the condition and the patient's response. Treatment effects typically appear within a few days and can last between 3 and 4 months.
Common side effects include dry mouth, fatigue, injection site pain, and muscle weakness. In rare cases, severe adverse reactions such as difficulty breathing or swallowing may occur. It is important that treatment is administered by an experienced specialist to minimize risks.
Botulinum toxin type B is an effective therapeutic option for managing neuromuscular disorders, contributing to improved quality of life for patients.
Botulinum toxin type B is administered via intramuscular injections, with the dose adjusted based on the severity of the condition and the patient's response. Treatment effects typically appear within a few days and can last between 3 and 4 months.
Common side effects include dry mouth, fatigue, injection site pain, and muscle weakness. In rare cases, severe adverse reactions such as difficulty breathing or swallowing may occur. It is important that treatment is administered by an experienced specialist to minimize risks.
Botulinum toxin type B is an effective therapeutic option for managing neuromuscular disorders, contributing to improved quality of life for patients.